Ozempic safety concerns: death lawsuit, FDA warnings, JAMA GI risks
Key Questions
What is the wrongful death lawsuit related to Ozempic?
A lawsuit against Novo Nordisk alleges wrongful death due to gastroparesis from Ozempic use. It raises new safety questions for the popular drug.
What FDA issues has Novo Nordisk faced with adverse events?
The FDA warned Novo Nordisk for not reporting serious adverse events and deaths promptly. This adds regulatory pressure amid delayed AE reporting.
What did the JAMA meta-analysis find on Ozempic GI risks?
A JAMA meta-analysis of 3 million patients highlighted gastrointestinal risks with GLP-1 drugs like Ozempic. It contributes to growing litigation and safety concerns.
FDA Mar'26 warning (post-'25 NJ insp) for failing to report serious ADEs/deaths timely on semaglutide (systemic); wrongful death suit (gastroparesis); JAMA meta-analysis GI risks in 3M pts; adds litigation/FDA pressure.
Sources (2)
Updated Apr 12, 2026